Skip to main content
Log in

Rituximab in refractory MuSK antibody myasthenia gravis

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hoch W, McConville J, Helms S et al (2001) Auto antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7:365–368

    Article  CAS  PubMed  Google Scholar 

  2. Evoli A, Tonali PA, Padua L et al (2003) Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126:2304–2311

    Article  PubMed  Google Scholar 

  3. Cragg MS, Walshe CA,Ivanov AO, Gleennie MJ (2005) The biology of CD20 and its potential as the target for mAb therapy. Curr Dir Autoimmun 8:140–174

    Article  CAS  PubMed  Google Scholar 

  4. Hain B, Jordan K, Deschauer M (2006) Successful treatment of MuSK antibodypositive myasthenia gravis with rituximab. Muscle Nerve 33(4):575–580

    Article  PubMed  Google Scholar 

  5. Wylam ME, Anderson PM, Kuntz NL, Rodriguez V (2003) Successful treatment of refractory myasthenia gravis using Rituximab: a pediatric case report. J Pediatr 143(5):674

    Article  PubMed  Google Scholar 

  6. Raja F, Russo D, Fuga G, Perella G, Baccarani M (2000) Rituximab for myasthenia gravis developing after bone marrow transplant. Neurology 55:1062–1063

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mona Thakre.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thakre, M., Inshasi, J. & Marashi, M. Rituximab in refractory MuSK antibody myasthenia gravis. J Neurol 254, 968–969 (2007). https://doi.org/10.1007/s00415-006-0442-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-0442-2

Keywords

Navigation